AVISO IMPORTANTE


A partir del día 14 de junio de 2015, domingo, este blog dejará de ser actualizado como se ha venido haciendo hasta la fecha. La primera idea fue la de cerrar el blog, pero el deseo que que cuanto aquí se ha publicado pueda seguir siendo útil en el futuro, nos hace que mantengamos abierto el blog. Si tuviera alguna duda o quisiera hacer algún comentario, no tema hacerlo: seguiremos publicando cuantos comentarios se hagan y seguiremos contestando a las dudas que puedan surgir.
Gracias y hasta siempre.
Andrés Guerrero Serrano
-Homeópata-

jueves, 14 de junio de 2012

Real-life effect of classical homeopathy in the treatment of allergies: A multicenter prospective observational study.

(Extraído de PubMed.gov)

Wien Klin Wochenschr. 2012 Jan;124(1-2):11-7. Epub 2011 Dec 8.

Gründling C, Schimetta W, Frass M.

Source

General and Homeopathic Medical Practice, Enns, Austria. praxis@drgruendling.at

Abstract
OBJECTIVE:

The prevalence of allergic disorders in western industrialized countries has steadily increased during the last three decades. Public acceptance of complementary treatment methods is high. The aim of this study was to assess the real-life efficacy of classical homeopathic treatment and the potential to reduce conventional medication dosage.

METHODS:

A prospective multicenter observational study was conducted by general practitioners specializing in homeopathy in nine Austrian test centers. Personal data and symptoms of allergic patients diagnosed with allergic conjunctivitis, allergic rhinitis, bronchial asthma and neurodermatitis before and after homeopathic treatment were assessed by means of questionnaires (classification of patients' condition by using visual analogue scales/VAS).

RESULTS:

40 out of 44 patients originally recruited for the trial were found to meet the eligibility criteria. All clinical symptoms were shown to improve substantially, in most cases quite markedly (p < 0.001). 21 patients undergoing conventional medication therapy at baseline (62%) were able to discontinue at least one medication, while the remaining patients (38%) reported a dose reduction in at least one medication. No side effects were reported during treatment.

CONCLUSION:

The symptoms of patients undergoing homeopathic treatment were shown to improve substantially and conventional medication dosage could be substantially reduced. While the real-life effect assessed indicates that there is a potential for enhancing therapeutic measures and reducing healthcare cost, it does not allow to draw conclusions as to the efficacy of homeopathic treatment per se.

PMID:
22138796
[PubMed - indexed for MEDLINE]

viernes, 8 de junio de 2012

Effectiveness of a herbal formula in women with menopausal syndrome.

(Extraído de PubMed.gov)

Forsch Komplementmed. 2011;18(5):264-8. doi: 10.1159/000333430. Epub 2011 Oct 10.

Yakoot M, Salem A, Omar AM.

Source

Green Clinics, Alexandria, Egypt. Yakoot@yahoo.com

Abstract
BACKGROUND:

Lady 4 is a combination of 4 natural components (evening primrose oil, damiana, ginseng, royal jelly) with a known history of traditional use for menopausal symptoms.

OBJECTIVE:

To study efficacy and safety of Lady 4 in women suffering from menopausal syndrome.

METHODS:

120 women with menopausal symptoms were randomised into an experimental group treated with 2 capsules of Lady 4 daily and a control group treated with placebo. The outcome was measured by the Menopause Rating Scale II (MRS-II).

RESULTS:

There was a statistically significant improvement in the MRS-II score in both groups after 2 and 4 weeks of treatment, but the improvement was significantly better in the Lady 4 group (p < 0.001). 86.7% in the Lady 4 group and 56.7% in the placebo group rated the therapy success as 'much improved' or 'very much improved'.

CONCLUSION:

Lady 4 may be beneficial in the treatment of menopausal syndrome and can be used as a safe natural promoter of health and well-being in women during the menopausal transition.

Copyright © 2011 S. Karger AG, Basel.

PMID:
22105039
[PubMed - indexed for MEDLINE]

Comparison of Swiss basic health insurance costs of complementary and conventional medicine.

(Extraído de Pubmed.gov)

Forsch Komplementmed. 2011;18(6):315-20. Epub 2011 Nov 25.

Studer HP, Busato A.

Source

hpstuder@swissonline.ch

Abstract
BACKGROUND:

From 1999 to 2005, 5 methods of complementary and alternative medicine (CAM) applied by physicians were provisionally included into mandatory Swiss basic health insurance. Between 2012 and 2017, this will be the case again. Within this process, an evaluation of cost-effectiveness is required. The goal of this study is to compare practice costs of physicians applying CAM with those of physicians applying solely conventional medicine (COM).

METHODS:

The study was designed as a cross-sectional investigation of claims data of mandatory health insurance. For the years 2002 and 2003, practice costs of 562 primary care physicians with and without a certificate for CAM were analyzed and compared with patient-reported outcomes. Linear models were used to obtain estimates of practice costs controlling for different patient populations and structural characteristics of practices across CAM and COM.

RESULTS:

Statistical procedures show similar total practice costs for CAM and COM, with the exception of homeopathy with 15.4% lower costs than COM. Furthermore, there were significant differences between CAM and COM in cost structure especially for the ratio between costs for consultations and costs for medication at the expense of basic health insurance. Patients reported better quality of the patient-physician relationship and fewer adverse side effects in CAM; higher cost-effectiveness for CAM can be deduced from this perspective.

CONCLUSION:

This study uses a health system perspective and demonstrates at least equal or better cost-effectiveness of CAM in the setting of Swiss ambulatory care. CAM can therefore be seen as a valid complement to COM within Swiss health care.

Copyright © 2011 S. Karger AG, Basel.

PMID:
22189362
[PubMed - indexed for MEDLINE]

jueves, 7 de junio de 2012

Homeopatía en Preoperatorio y Postoperatorio

(Extraído de alumyna.com)

Los principales medicamentos homeopáticos utilizados en el pre y postoperatorio, son:

Para tratar de eliminar la ansiedad y los miedos: Aconitum Napellus a iniciar72 horas antes de la cirugía, 30 ch cada mañana.

Para contrarrestar los efectos anestésicos: Nux Vómica tratamiento a iniciar 24 horas antes y después de la cirugía, por la mañana 30CH

Disminución del trauma quirúrgico: Árnica Montana 30 ch durante 7 días al menos 2 veces al dfía, después de la operación cada vez que sienta dolor. Con este remedio también evitaremos infecciones.

Disminución del dolor postoperatorio: Aconitum Napellus 30 ch y Árnica Montana 30 ch.

Si existen dolores viscerales Magnesia Phosphorica 30ch,  2 veces al día por cinco días.

Náuseas y Vómito: Ipeca 5 o 3o ch 2 veces por 72 horas.

Hipertensión Arterial Preoperatoria: Aconitum Napellus 5, 30 ch.

Control sangrado Intra y postoperatorio Phosphorus 5,30 LM, 2 series al día, 72 horas y 48 después de la cirugía.

Meteorismo Postoperatorio Magnesia phosphorica 30 ch 2 series al día.

Embolia Pulmonar Bryonia Alba 5, 30 ch.

Estos medicamentos preferiblemente se deben diluir en agua, pero si no se puede beber, en nolitas sublinguales.

En resumen, según el tipo de intervención se debe tener en cuenta que:

- Aconitum mejora los miedos y la ansiedad

- Arnica, dolor, inflamación, hemorragias e infección

- phosphorus, hemorragias

Si se toca abdomen, magnesia phosphorica también.

Short-term study on the effects of rosemary on cognitive function in an elderly population.

(Extraído de PubMed.gov)

J Med Food. 2012 Jan;15(1):10-7. Epub 2011 Aug 30.

Pengelly A, Snow J, Mills SY, Scholey A, Wesnes K, Butler LR.

Source

Herbal Medicine Department, Tai Sophia Institute, Laurel, Maryland 20723, USA. apengelly@tai.edu

Abstract

Rosemary (Rosmarinus officinalis L.) has traditional reputations that justify investigation for a potential role in reducing widespread cognitive decline in the elderly. A randomized, placebo-controlled, double-blinded, repeated-measures crossover study was conducted to investigate possible acute effects of dried rosemary leaf powder on cognitive performance. Twenty-eight older adults (mean age, 75 years) were tested using the Cognitive Drug Research computerized assessment system 1, 2.5, 4, and 6 hours following a placebo and four different doses of rosemary. Doses were counterbalanced, and there was a 7-day washout between visits. There was a biphasic dose-dependent effect in measures of speed of memory: the lowest dose (750 mg) of rosemary had a statistically significant beneficial effect compared with placebo (P=.01), whereas the highest dose (6,000 mg) had a significant impairing effect (P<.01). There were significant deleterious effects on other measures of cognitive performance, although these were less consistent. Speed of memory is a potentially useful predictor of cognitive function during aging. The positive effect of the dose nearest normal culinary consumption points to the value of further work on effects of low doses over the longer term.

PMID:
21877951
[PubMed - indexed for MEDLINE]

Induction of cancer cell death by isoflavone: the role of multiple signaling pathways.

(Extraído de PubMed.gov)

Nutrients. 2011 Oct;3(10):877-96.

Li Y, Kong D, Bao B, Ahmad A, Sarkar FH.

Source

Department of Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, 740 Hudson Webber Cancer Research Center, 4100 John R, Detroit, MI 48201, USA. yiweili@med.wayne.edu

Abstract

Soy isoflavones have been documented as dietary nutrients broadly classified as "natural agents" which plays important roles in reducing the incidence of hormone-related cancers in Asian countries, and have shown inhibitory effects on cancer development and progression in vitro and in vivo, suggesting the cancer preventive or therapeutic activity of soy isoflavones against cancers. Emerging experimental evidence shows that isoflavones could induce cancer cell death by regulating multiple cellular signaling pathways including Akt, NF-κB, MAPK, Wnt, androgen receptor (AR), p53 and Notch signaling, all of which have been found to be deregulated in cancer cells. Therefore, homeostatic regulation of these important cellular signaling pathways by isoflavones could be useful for the activation of cell death signaling, which could result in the induction of apoptosis of both pre-cancerous and/or cancerous cells without affecting normal cells. In this article, we have attempted to summarize the current state-of-our-knowledge regarding the induction of cancer cell death pathways by isoflavones, which is believed to be mediated through the regulation of multiple cellular signaling pathways. The knowledge gained from this article will provide a comprehensive view on the molecular mechanism(s) by which soy isoflavones may exert their effects on the prevention of tumor progression and/or treatment of human malignancies, which would also aid in stimulating further in-depth mechanistic research and foster the initiation of novel clinical trials.

PMID:
22200028
[PubMed - indexed for MEDLINE]
PMCID:
PMC3244210
Free PMC Article

sábado, 2 de junio de 2012

Anticancer, chemopreventive and radioprotective potential of black plum (Eugenia jambolana lam.).

(Extraído de PubMed.gov)

Asian Pac J Cancer Prev. 2011;12(1):3-15.

Baliga MS.

Source

Research and Development, Father Muller Medical College, Mangalore, Karnataka, India. msbaliga@gmail.com

Abstract

Despite good understanding of the molecular basis of the disease and advances in treatment, globally cancer is still a major cause of death. Estimates are that it will surpass cardiovascular disease as the leading cause of death, with higher incidences in the developing countries that have minimal resources. Chemotherapy and radiotherapy, the two most commonly used treatment modalities, are associated with untoward side effects. This has necessitated the search for alternatives that are effective, non toxic and easily affordable for patients and traditional medicinal plants are an ideal source. Eugenia jambolana Lam., commonly known as black plum or 'jamun' is an important medicinal plant in various traditional systems of medicine. It is effective in the treatment of diabetes mellitus, inflammation, ulcers and diarrhea and preclinical studies have also shown it to possess antineoplastic, chemopreventive and radioprotective properties. Here, for the first time, the effects of jamun in treatment and prevention of cancer, and the mechanisms responsible for these effects are appraised. Additionally the drawbacks in existing knowledge are also stressed to emphasize the possible avenues that need to be investigated, so that maximum effects on both prevention and cure can be attained.

PMID:
21517226
[PubMed - indexed for MEDLINE]